CXCL11: A Novel Biomarker in Colorectal Cancer as Metastasis Predictor

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• CXCL11 (C-X-C motif chemokine ligand 11) is a chemokine involved in immune and inflammatory responses.
• Colorectal cancer (CRC) metastasis remains a significant clinical challenge.
• Identifying reliable biomarkers for metastasis is crucial for patient outcomes.

Purpose of the Study:

• To investigate the association between variations in CXCL11 gene expression and the presence of metastasis in colorectal cancer (CRC) patients.
• To evaluate the potential of CXCL11 as a biomarker for detecting or predicting metastasis in CRC.

Main Methods:

• Observational laboratory-based study using 60 fresh CRC tumor tissue samples.
• Gene expression analysis of CXCL11 performed using Polymerase Chain Reaction (PCR).
• Tissue samples collected from patients undergoing biopsies or tumor resections.

Main Results:

• Significant variations in CXCL11 gene expression were observed in relation to CRC cancer stage (P = 0.015) and metastasis status (P = 0.017).
• No significant association was found between CXCL11 expression and patient age, gender, anatomical pathology, or tumor location.
• CXCL11 expression levels differed significantly between metastatic and non-metastatic CRC cases.

Conclusions:

• CXCL11 gene expression variations are significantly associated with metastasis in colorectal cancer patients.
• CXCL11 shows potential as a biomarker for colorectal cancer metastasis.
• Further research with larger cohorts is recommended to validate these findings and explore CXCL11's therapeutic potential in CRC.